한국어
English
日本語
中文(简体)
Pretal Extended Release Capsule (Cilostazol)
100mg
Hard capsule · Prescription medication
Korea Otsuka Pharmaceutical Co., Ltd.
Cilostazol is an ingredient that improves blood circulation by dilating peripheral blood vessels and inhibiting platelet aggregation.
MFDS ingredient code M252025
Cilostazol is a medication that improves blood circulation, belonging to the class of phosphodiesterase inhibitors that have effects of platelet aggregation inhibition and vascular dilation. It is mainly used for the treatment of peripheral vascular diseases to facilitate blood flow.
Cilostazol prevents the adhesion of platelets within blood vessels, thereby preventing thrombus formation. Additionally, it relaxes vascular muscles to widen blood vessels and helps blood flow smoothly.
Approved uses differ by product. Check each product's information for its actual use.
Unlike other platelet inhibitors, cilostazol has the added effect of vasodilation, making it particularly useful in the treatment of peripheral vascular diseases. The micronized form enhances absorption rates, ensuring stable efficacy.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.
